{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:31:25Z","timestamp":1770280285691,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2283,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1111\/j.1365-2133.2009.09068.x","type":"journal-article","created":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T14:46:08Z","timestamp":1236609968000},"page":"1258-1263","source":"Crossref","is-referenced-by-count":18,"title":["Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours"],"prefix":"10.1093","volume":"160","author":[{"given":"Y.","family":"Hida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Arase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/434829a","article-title":"Aborting the birth of cancer","volume":"434","author":"Venkitaraman","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrc1884","article-title":"The power and the promise of oncogene-induced senescence markers","volume":"6","author":"Collado","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication","volume":"444","author":"Di Micco","year":"2006","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature05268","article-title":"Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints","volume":"444","author":"Bartkova","year":"2006","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2004.11.012","article-title":"Cell responses to FGFR3 signaling: growth, differentiation and apoptosis","volume":"304","author":"L\u2019H\u00f4te","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","article-title":"Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors","volume":"158","author":"Billerey","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB10","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M","article-title":"The incidence of thanatophoric dysplasia mutations in FGFR3 genes is higher in low-grade or superficial bladder carcinomas","volume":"92","author":"Kimura","year":"2001","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB11","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1158\/0008-5472.CAN-03-2421","article-title":"FGFR3 and p53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma","volume":"64","author":"van Rhijn","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijc.21145","article-title":"Constitutive activating mutation of the FGFR3b in oral squamous cell carcinoma","volume":"117","author":"Zhang","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB14","first-page":"3541","article-title":"Mutation in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers","volume":"61","author":"Jang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/carcin\/bgi290","article-title":"Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b","volume":"27","author":"Bernard-Pierrot","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/hmg\/ddi127","article-title":"Activating mutations of tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans","volume":"14","author":"Logi\u00e9","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB17","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/sj.jid.5700422","article-title":"High frequency of FGFR3 mutations in adenoid seborrheic keratoses","volume":"126","author":"Hafner","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB18","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4161\/cc.5.23.3509","article-title":"FGFR3 mutations in benign skin tumors","volume":"5","author":"Hafner","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/sj.jid.5700804","article-title":"Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses","volume":"127","author":"Hafner","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/modpathol.3800837","article-title":"FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization","volume":"20","author":"Hafner","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Gorgoulis","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.11.042","article-title":"Three cases of Bowen\u2019s disease on the lower abdomen associated with high-risk types 16, 33, and 59 of human papillomavirus","volume":"52","author":"Murao","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2005.06365.x","article-title":"Bowen\u2019s disease on the sole: p16INK4a overexpression associated with human papillomavirus type 16","volume":"152","author":"Murao","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/1078-0432.459.11.2","article-title":"Fibroblast growth factor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth","volume":"11","author":"G\u00f3mez-Rom\u00e1n","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-002-0333-z","article-title":"Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin","volume":"294","author":"Takenaka","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB26","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI28163","article-title":"Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi","volume":"116","author":"Hafner","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB27","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1038\/sj.onc.1204651","article-title":"No evidence of somatic FGFR3 mutation in various types of carcinoma","volume":"20","author":"Karoui","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB28","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2009.09068.x-BIB29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2133.2003.05654.x","article-title":"p16INK4a expression in actinic keratosis and Bowen\u2019s disease","volume":"149","author":"Salama","year":"2003","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09068.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09068.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T08:54:33Z","timestamp":1684918473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/6\/1258\/6641863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09068.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}